Page last updated: 2024-09-05
erlotinib and nu 7026
erlotinib has been researched along with nu 7026 in 1 studies
Compound Research Comparison
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (nu 7026) | Trials (nu 7026) | Recent Studies (post-2010) (nu 7026) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 70 | 0 | 44 |
Protein Interaction Comparison
| Protein | Taxonomy | erlotinib (IC50) | nu 7026 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 6.4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 0.2388 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Other Studies
1 other study(ies) available for erlotinib and nu 7026
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |